UNSPSC 51271912: Procaine

This classification denotes an anesthetic agent with the molecular formula C13H20N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4Z8Y51M438, chemically known as procaine, base but generally known as procaine, which bears US NIH Compound Identifier 4914. European Medicines Agency schedules Procaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10056MIG. The term PROCAINE is an International Non-Proprietary Name.

UNSPSC 51271912 Procaine, a Commodity code, reflects state and local procurement of generic pharmaceuticals and over-the-counter products through cooperative purchasing vehicles and established drug distribution channels. State and local governments acquire these products primarily through multistate cooperative agreements that aggregate demand across participating jurisdictions and healthcare facilities. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, is the issuing body for recent activity under this code, directing suppliers to deliver products through three authorized wholesalers: AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC. Vendors must hold current Good Manufacturing Practices (cGMP) and Drug Supply Chain Security Act (DSCSA) certification, maintain contractual relationships with at least two of the three authorized wholesalers with chargeback systems, and carry commercial general liability insurance of $5 million per occurrence, network security and privacy liability of $2 million, and professional liability of $2 million. Pricing is weighted heavily (75 percent) in evaluation, with secondary weight on price format compliance (10 percent), EDI capability (5 percent), administrative fee acceptance (5 percent), and data format compliance (5 percent).

MMCAP's January 2026 RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802) represents the most recent solicitation under this code, with proposals due March 26, 2026, and a question cutoff of February 18, 2026. The RFP anticipates contract awards to become effective July 1, 2026, with a two-year initial term for new vendors and optional extensions at MMCAP's discretion; incumbent vendors' amendments align through June 30, 2028. All products must be available in the marketplace by May 15, 2026, with expiration dates of at least one year from manufacture and a minimum six-month shelf life. Vendors must submit detailed product information including National Drug Codes (NDC), SKUs, UPCs, generic descriptions, strength, dosage form, trade names, and packaging configurations through MMCAP's ePro procurement system in CSV format. The solicitation encompasses multiple award potential across participating state and local government facilities in Minnesota and Oregon, with performance penalties ranging from $200 to $1,500 per violation.